Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Agnico Eagle Mines Ltd (AEM) vs TransMedics Group Inc (TMDX) Price & Performance

Agnico Eagle Mines LtdTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Agnico Eagle Mines Ltd vs TransMedics Group Inc — how do they compare? Agnico Eagle Mines Ltd trades at $186.57 (market cap $92.01B), while TransMedics Group Inc trades at $87 (market cap $3.10B). The key difference: Agnico Eagle Mines Ltd is far larger — about 29.7× TransMedics Group Inc's market cap, and Agnico Eagle Mines Ltd pays a 0.99% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

AEMTMDX
Market Cap
$92.01B$3.10B
Sector
Basic MaterialsTechnology
52-Week High
$252.19$150.42
52-Week Low
$130.23$61.99
Enterprise Value
$88.85B$3.49B
Dividend Yield
0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Agnico Eagle Mines Ltd

Agnico Eagle Mines (AEM) trades at $180.48, up 0.93% today, with strong quarterly earnings beats and bullish analyst consensus. The stock shows robust fundamentals with a P/E of 15.56, net income margin of 40.44%, and record free cash flow of $6.82B in 2025. Recent news highlights operational strength amid gold price gains, though cost pressures are noted.

Outlook remains positive with a $219.63 price target and 67.7% buy ratings, supported by organic growth plans. Risks include rising production costs and gold price volatility. The stock offers upside potential but faces margin compression headwinds in 2026.

TransMedics Group Inc

TransMedics Group (TMDX) trades at $86.43, down 2.24% amid recent earnings misses but maintains strong analyst support with a $99.57 consensus target. The stock shows bullish technical signals with support at $84-87, though RSI levels suggest overbought conditions. Fundamentally, the company demonstrates robust profitability with 58.69% gross margins and 22.69% net income margins, despite recent quarterly earnings falling short of expectations.

Investment outlook remains positive given strong institutional backing and growth potential in organ transplant technology, though risks include ongoing fiduciary investigations and margin pressure from increased operating costs. The stock offers 15% upside to consensus targets but requires monitoring of Q3 earnings performance and legal developments.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Agnico Eagle Mines Ltd

Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.

Read more on AEM

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX